Addus HomeCare stock crossed its 200-day average on October 2

Published on 10/05/2026 at 12:33 | Editorial responsibility: Rafael Müller, Editor-in-Chief AD HOC NEWS

Addus HomeCare stock traded at USD 111.27 after the October 2 Nasdaq close and reached USD 113.08 during the session. Second-quarter revenue hit USD 377.4 million.

ADUS, US0067391062, Illustration mit AI erstellt.

Addus HomeCare (ISIN US0067391062) stock closed at USD 111.27 on Nasdaq on October 2, 2026, after trading above its 200-day average. MarketBeat reported that the shares reached USD 113.08 during the session, compared with a 200-day average of USD 104.39. That puts the chart signal in the context of a USD 87.95 to USD 124.43 52-week range.

AccentCare adds scale

On September 14, 2026, Addus announced an agreement to acquire AccentCare's personal care division outside New York for an anticipated purchase price of USD 275.0 million. Business Wire said the acquired operations serve 13,700 customers across a 10-state footprint.

The transaction is expected to add USD 280 million in annualized personal care revenue, representing a 19 percent increase to Addus' revenue base. Addus plans to fund the purchase with a combination of its revolver and cash on hand, while completion remains subject to regulatory approvals and customary closing conditions, according to Business Wire.

Second-quarter growth sets the base

Addus reported USD 377.4 million in net service revenue for the second quarter of 2026, up 8.0 percent from the year-earlier quarter. Adjusted diluted EPS rose 16.1 percent year over year to USD 1.73, while GAAP diluted EPS was USD 1.49, according to MarketBeat.

The revenue figure exceeded the USD 376.24 million consensus estimate by USD 1.17 million, and adjusted EPS came in USD 0.03 above the USD 1.70 estimate. The comparison matters because the AccentCare deal adds scale while the latest quarter shows the existing business continuing to expand.

Analysts split on valuation

MarketBeat lists a Moderate Buy consensus based on 11 analysts, with an average price target of USD 129.33, a high of USD 142.00 and a low of USD 96.00. The average target is 16.3 percent above the USD 111.27 closing price on October 2, 2026.

The counterweight is analyst caution over organic growth and public reimbursement exposure. Investing.com reported on September 14, 2026, that BofA Securities cut its rating from Buy to Neutral and reduced its price target from USD 140 to USD 125.

Stock stays below its yearly high

ADUS closed at USD 111.27 on Nasdaq on October 2, 2026, down USD 0.43, or 0.38 percent, from the prior close. Its USD 2.1 billion market capitalization and the 10.6 percent gap to the USD 124.43 52-week high frame the acquisition story against a still-range-bound share price.